Baxter announces CE mark and regulatory approval of new Evo IQ Infusion System for New Zealand
Saturday, 4 August 2018
Return to eHealthNews.nz home page Baxter International Inc., a leader in innovative technology for medication delivery, today announced the CE marking of the Evo IQ infusion system.
In addition to the planned marketing of the device in the United Kingdom, Ireland and New Zealand, the Evo IQ infusion system recently received regulatory approval by the Therapeutic Goods Administration in Australia.
These markets represent the first in a series of planned regulatory submissions for the Evo IQ Infusion System in countries around the world, with commercial launch activities starting in the third quarter of 2018.
The Evo IQ Infusion System features a scalable platform and user-centric design that includes an advanced drug library and dose error reduction software to promote patient safety, intuitive clinical workflows to help optimise clinician efficiency and Baxter’s One Set technology, which allows clinicians to easily switch between gravity and pump applications without changing sets, reducing disconnects and set changes and may help reduce opportunities for touch contamination, along with helping to reduce IV tubing use and costs.
“With the Evo IQ Infusion System, Baxter is extending its leading-edge infusion systems technology to help increase drug library compliance and protect patient infusions in the UK, Ireland, Australia and New Zealand,” said Baxter general manager medication delivery David Ferguson.
“The Evo IQ Infusion System provides healthcare facilities with access to Baxter’s proven infusion safety technology in an adaptable system that can grow with their needs.”
Source: Baxter International media release, 1 August 2018
Sector updates are provided by organisations to eHealthNews.nz and have not necessarily been edited or checked for accuracy. Any queries should be directed to the organisation issuing the release.
Do you have an item to add to sector updates?
Email your information to us at updates@hinz.org.nz Return to eHealthNews.nz home page
|
Email to a Friend